THE RUSSIAN COUNCIL OF ExPERTS FOR IMPROVEMENT THE APPROACHES TO THE TREATMENT OF OSTEOPOROSIS

The meeting of the Russian Council of Experts for improvement the approaches to the treatment of osteoporosis (OP) was held in Moscow on December 4, 2014. Leading Russian and Switzerland specialists in orthopedics, traumatology and rheumatology attended the meeting as well as members of Russian unit of clinical department AOTrauma of the international public (non-government) organization AOFoundation and members of the Russian Osteoporosis Association. The participants of the Russian Council of Experts have discussed the system of care for patients with OP in the Russian Federation. They discussed the need for the development of measures to optimize interdisciplinary interaction between orthopedic surgeons and internal medicine specialists in the treatment of patients with OP to reduce the number of postsurgical complications and prevention of further vertebral and nonvertebral fractures. Experts have noted the need to raise the level of knowledge about OP in orthopedic surgeons, clinical characteristics of fractures in patients with OP and measures to control it; to raise awareness of OP among patients by billboards in clinics and outpatient emergency rooms; to develop and implement into clinical practice of orthopedic surgeons standard of care for elderly patients with fragility fractures; to develop algorithm of secondary fractures prevention through the prescription of pathogenic OP therapy at the level of the trauma unit; to form an interdisciplinary system of the medical care for patient with fragility fractures, as well as contribute to the organization of the service Secondary Fractures Prevention (Fracture Liaison Service) in the Russian health care system.

Council of Experts, osteoporosis, fragility fractures, secondary fractures prevention, treatment, teriparatide

1. Зоткин Е.Г., Косульникова Е.Н. Остеопороз: от организации помощи больным к лечению. Медлайн экспресс. -2007. - № 1 (190). - С. 56-59.

2. Лесняк О. М. Аудит состояния проблемы остеопоро-за в Российской Федерации. Профилактическая медицина. 2011, т. 14(2): 7-10

3. Lönnroos E, Kautiainen H, Karppi P, Hartikainen S, Kiviranta I, Sulkava R. Osteoporos Int. 2007 Sep; 18(9): 1279-1285.

4. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M. Patients with prior fractures have an increased risk of future fractures: a Summary of the literature and statistical synthesis. J Bone Miner Res. 2000 Apr; 15(4): 721-739.

5. Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344(19): 1434-1441.

6. Prevrhal S, Krege JH, Chen P et al. Teriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment. Curr Med Res Opin. 2009; 25(4): 921-928.

7. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF. Recombinant human parathyroid hormone (134) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res. 2003 Nov; 18(11): 1932-1941.

8. Kleerekoper M, Greenspan SL, Lewiecki EM, Miller PD, Kendler DL, Maricic M, Keaveny TM, Kopperdahl DL, Ruff VA, Wan X, Janos B, Krohn K. Assessing the Effects of Teriparatide Treatment on Bone Mineral Density, Bone Microarchitecture, and Bone Strength. J Bone Joint Surg Am. 2014 Jun 4; 96(11): e90.

9. Obermayer-Pietsch BM, Marin F, McCloskey EV et al. Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorbtive treatment. J Bone Miner Res. 2008; 23(10): 1591-1600.

10. Первый опыт организации в Санкт-Петербурге вторичной профилактики повторных остеопоротических переломов костей в рамках программы «Прометей» Российской ассоциации по остеопорозу. Фарматека. 2014, № 5-14: 12-17.